There’s evidence that the demographic of people on the drugs overlaps with those who like to spend, a group some analysts ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Life on a fastball means movement. When Williams' fastball is right, it rides up on a hitter. Vogt has seen that ride ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

European Union trade chief Maros Sefcovic said on Thursday that his top priority in trade talks with President Donald Trump's ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...

Discover the hidden medical causes, psychological factors, and lifestyle changes that may explain the reasons for the unexpectedly weight loss.

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...